Search Results

MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Cybersecurity is pleased to announce its role in the granting of the DeNovo by the U.S. Food and Drug Administration (FDA) for BONESUPPORT’S CERAMENT G.

BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its leadership team that will take place June 1, 2020.

BONESUPPORT™ , an emerging leader in orthobiologics for the management of bone voids, is now the exclusive distributor of CERAMENT® in the United States.

BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announced that the company will submit a De Novo application to the US Food and Drug Administration to obtain a market approval for the company’s antibiotic-releasing product CERAMENT G.